Thomas Gallaway Corporation – Trademark Portfolio
Entity Type: 03
Thomas Gallaway Corporation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ONEPOINT and TECHNOLOGENT. The owner is based in Irvine, CA.
100 Spectrum Center Drive, Suite 700
Irvine, CA 92618
Showing of trademarks Trademarks
Trademark Classifications
Thomas Gallaway Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Thomas Gallaway Corporation have?
Thomas Gallaway Corporation has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 abandoned.
What trademark classes does Thomas Gallaway Corporation file in?
Thomas Gallaway Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 37 (Building & Construction). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Thomas Gallaway Corporation's most well-known trademarks?
Thomas Gallaway Corporation's registered trademark portfolio includes well-known marks such as ONEPOINT and TECHNOLOGENT. These are among 2 currently registered trademarks in the portfolio.
What is Thomas Gallaway Corporation's trademark registration success rate?
Thomas Gallaway Corporation has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.